ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,051.09
0.00%
Dow Jones
43,828.06
-0.20%
US Dollar vs MXN
20.1304
0.00%
Brent Oil
74.135
0.00%
Bitcoin
101,651.38
0.19%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Wolters Kluwers NV (WKL) Cotización

Wolters Kluwers NV

Wolters Kluwers NV (WKL)

EU
162.40
0.20
(0.12%)
Cerrado 13 Diciembre 10:30AM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
162.40
Postura de Compra
162.00
Postura de Venta
163.95
Volume Operado de la Acción
490,122
161.85 Rango del Día 163.60
126.60 Rango de 52 semanas 164.60
Capitalización de Mercado [m]
39.059B
Precio Anterior
162.20
Precio de Apertura
162.25
Hora
837
@
162.4
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
453,888
Acciones en circulación
240,511,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
38.79
Beneficio por acción (BPA)
4.19
turnover
5.58B
Beneficio neto
1.01B

Acerca de Wolters Kluwers NV

Sector
Prepackaged Software
Industria
Book Printing/publishing
Sitio web
www.wolterskluwer.com
Sede
Alphen Aan Den Rijn, South Holland, Nld
Fundado
1986
Wolters Kluwers NV is listed in the Prepackaged Software sector of the Euronext with ticker WKL. The last closing price for Wolters Kluwers NV was 162.20 €. Over the last year, Wolters Kluwers NV shares have traded in a share price range of 126.60 € to 164.60 €.

Wolters Kluwers NV currently has 240,511,000 shares in issue. The market capitalisation of Wolters Kluwers NV is 39.01 € billion. Wolters Kluwers NV has a price to earnings ratio (PE ratio) of 38.79.

WKL Últimas noticias

Más noticias

Share Buyback Transaction Details December 5 – December 11, 2024

Share Buyback Transaction Details December 5 – December 11, 2024 PRESS RELEASE                                         Share Buyback Transaction Details December 5 – December 11, 2024 Alphen aan...

12 Diciembre 2024
UK Regulatory

Wolters Kluwer N.V.: Wolters Kluwer appoints Mark Sherwood as Executive Vice President & Chief Information Officer

Wolters Kluwer N.V.: Wolters Kluwer appoints Mark Sherwood as Executive Vice President & Chief Information Officer PRESS RELEASE Wolters Kluwer appoints Mark Sherwood as Executive Vice...

09 Diciembre 2024
UK Regulatory

Wolters Kluwer N.V.: Wolters Kluwer appoints Mark Sherwood as Executive Vice President & Chief Information Officer

PRESS RELEASE Wolters Kluwer appoints Mark Sherwood as Executive Vice President & Chief Information Officer Alphen aan den Rijn – December 9, 2024 - Wolters Kluwer, a global leader in...

09 Diciembre 2024
GlobeNewswire Inc.

Share Buyback Transaction Details November 28 – December 4, 2024

Share Buyback Transaction Details November 28 – December 4, 2024 PRESS RELEASE                                         Share Buyback Transaction Details November 28 – December 4, 2024 Alphen aan...

05 Diciembre 2024
UK Regulatory

Share Buyback Transaction Details November 21 – November 27, 2024

Share Buyback Transaction Details November 21 – November 27, 2024 PRESS RELEASE                                         Share Buyback Transaction Details November 21 – November 27, 2024 Alphen...

28 Noviembre 2024
UK Regulatory

Share Buyback Transaction Details November 14 – November 20, 2024

Share Buyback Transaction Details November 14 – November 20, 2024 PRESS RELEASE                                         Share Buyback Transaction Details November 14 – November 20, 2024 Alphen...

21 Noviembre 2024
UK Regulatory

Share Buyback Transaction Details November 7 – November 13, 2024

Share Buyback Transaction Details November 7 – November 13, 2024 PRESS RELEASE                                         Share Buyback Transaction Details November 7 – November 13, 2024 Alphen aan...

14 Noviembre 2024
UK Regulatory

Share Buyback Transaction Details October 31 – November 6, 2024

Share Buyback Transaction Details October 31 – November 6, 2024 PRESS RELEASE                                         Share Buyback Transaction Details October 31 – November 6, 2024 Alphen aan...

07 Noviembre 2024
UK Regulatory

Wolters Kluwer 2024 Nine-Month Trading Update

Wolters Kluwer 2024 Nine-Month Trading Update Wolters Kluwer 2024 Nine-Month Trading Update Alphen aan den Rijn, October 30, 2024 – Wolters Kluwer, a global leader in professional information...

30 Octubre 2024
UK Regulatory

Wolters Kluwer 2024 Nine-Month Trading Update

Wolters Kluwer 2024 Nine-Month Trading Update Alphen aan den Rijn, October 30, 2024 – Wolters Kluwer, a global leader in professional information, software solutions and services, today releases...

30 Octubre 2024
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-1.4-0.854700854701163.8164.15160462865162.24341471DE
44.452.81734726179157.95164.6151.05475398158.2265403DE
125.43.43949044586157164.6149.25453888157.32358391DE
2610.46.84210526316152164.6145.65419753155.11277891DE
5228.521.284540702133.9164.6126.6451019147.30841207DE
15658.856.7567567568103.6164.684.18490568117.74306811DE
26098.2152.95950155864.2164.652.0453255498.86751539DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALMARMare Nostrum
0.41 €
(51.85%)
21.31k
MLUMGUmalis Group
1.54 €
(45.28%)
1.7k
ALTROTronic s Microsystems
5.00 €
(44.51%)
167
IPHInnate Pharma
1.90 €
(22.58%)
579.44k
ALBOOBOOSTHEAT
0.209 €
(21.87%)
15.75k
MLGEQGentlemen S Equity SA
0.008 €
(-33.33%)
34k
MLIMLImalliance
0.346 €
(-23.11%)
10.58k
ALNEVNeovacs
1.60 €
(-17.52%)
2.38k
ALGTRGroupe Tera SA
2.04 €
(-15.00%)
100
NXFILNX Filtration NV
3.53 €
(-14.11%)
745.94k
ATOAtos SE
0.0023 €
(-11.54%)
4.75B
BCPBanco Comercial Portugues SA
0.4458 €
(1.16%)
48.07M
VIVVivendi SE
8.30 €
(-2.81%)
27.05M
ALHPIHopium SA
0.008 €
(0.00%)
23.6M
ALCYBCybergun
0.0001 €
(0.00%)
20.46M

Discusión

Ver feed completo
NoMoDo NoMoDo 5 minutos hace
True. Many.
HMBL
Researchfyi Researchfyi 5 minutos hace
Another week passes and LQMT’s share price is down 3.37% from 0.0445 cents to 0.043 cents on extremely weak trading volumes and little interest. The same when LQMT moves up or down.

The share price languishes in a coma like the new contracts anticipated for almost three years now.
LQMT
NoMoDo NoMoDo 6 minutos hace
Well done... you deserve a gold star. George Sharp knew HMBL's technology years ago and stated that a company with that kind of tech could replace the DTC, a 3 trillion dollar a year industry. The patent that was just granted, involved a method of handling a stock exchange. They specifically ment
DTC HMBL SMX
Dapper1 Dapper1 7 minutos hace
Ybyra meeting set for Dec 17th - See my earlier post for more info!
HMBL
3331 3331 10 minutos hace
BIEL: ACTIPATCH HUGE IN TAIWAN!

https://www.actipatchtw.com/general-1?pgid=lw...d04755314e
3331 3331 10 minutos hace
BIEL: ACTIPATCH HUGE IN TAIWAN!

https://www.actipatchtw.com/general-1?pgid=lw...d04755314e
NoMoDo NoMoDo 11 minutos hace
As well as who? Your other personality? Odd post.I didn't know the mods were investors here as well
Hmmm
HMBL
Zorax Zorax 11 minutos hace
Biscardi and girlfriend still awol.
But Bigfoot wanted me to wish "everyone on the board a happy holiday and Merry Christmas to all. And may biscardi get rocks under his tree"
He's such a softy.

It's still a mystery bigger than Bigfoot as to why this stock is still liste
LRDG
Hunterdave Hunterdave 11 minutos hace
With All that said, you'll be selling half of your shares, right?
Per your previous posts.
Please don't delete..you'll go against the TOS
Knock it off
HMBL
NoMoDo NoMoDo 12 minutos hace
No. I was a moderator when I owned 15mil. I had my posts deleted by the bashers regularly until I became a mod. Now I will private message anyone who breaks the rules and ask them to stay within the limits so I don't need to baby sit. I would be questioning why we have 2 mods that daily call the
HMBL
Konaploinks Konaploinks 12 minutos hace
Exactly Doc. The parallel universe. ….. We have reached. The Outer Limits Who’d a thunk it in our lifetime? Beam me up Peter. 😱
IONQ
StockItOut StockItOut 13 minutos hace
And of course, Brookmount intentionally misleads its prospective and current shareholders in it claiming it seeks "additional" high-quality gold assets with JORC/NI 43-101 verified reserves, when it currently has none, to "add" to.
BMXI
TJ HUNT TJ HUNT 13 minutos hace

I actually went to visit the Hospital today and I'm truely amazed that our CEO was able to generate millions of dollars with that facility. The Hospital is pretty old but the st
RNVA
3331 3331 14 minutos hace
BIEL: ActiPatch for Painsomnia!
https://www.facebook.com/share/p/1AhFGyNFqC/
3331 3331 14 minutos hace
BIEL: ActiPatch for Painsomnia!
https://www.facebook.com/share/p/1AhFGyNFqC/
Monk4444 Monk4444 14 minutos hace
Den
Seve is one of the biggest bashers here.
You are kind to respond to him/her but it's a waste of time.
AMRN
MartinLutherKing MartinLutherKing 15 minutos hace
What happened to 7th RNA Targeted Drug Discovery & Development Summit InBoston? TTX scam missing in action? Accelerating Safe & Potent RNA-Targeting Small Molecules Towards the Clinic??
all i see is a real company Remix Therapeutics joining forces with Roche and Daiichi Sankyo partnering wit
RNAZ
Zorax Zorax 15 minutos hace
Looks like some shareholders are throwing in the towel. Got a link for that?
It's not for the faint of heart having to wait for the corrupt FDA... The FDA isn't corrupt,,, yet. It's their job and they do it well. The FDA waits on the uhp corp to deliver the proper paperwork. It's on the scam
UEEC
WilliamMunny WilliamMunny 16 minutos hace
That sounds flattering at first blush, Hoskuld, but upon further consideration I will defer to the more experienced Martha Stewart on this topic…
AVXL
EmpressMonk25 EmpressMonk25 17 minutos hace
Or companies 😜
HMBL
tjvs tjvs 17 minutos hace
Did you ever call Saul .He's waiting 😂
TSOI
Dapper1 Dapper1 19 minutos hace
On the X TSNP HMBL OG's chatboard there was information posted a couple of hours ago regarding Ybyra Capital having a meeting to discuss the SMX merger and other topics on Tuesday, December 17th!
Key takeaway: Ybyra Capital mentioned taking advantage of SMX's technologies and to have access
HMBL SMX
rosemountbomber rosemountbomber 19 minutos hace
Not sure if we were discussing a couple of different things.  Your post seems to address taking a public company private and I agree.  The other topic was about whether a company is required to get approval for a RS. Most times I have seen companies have to get shareholders to vote on that but appar
AMRN
Tadaaa Tadaaa 20 minutos hace
OTC and SEC had not recognized that as of yet, still a Shell at this writing
NFTM

Su Consulta Reciente

EU
WKL
Wolters Kluwers NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados